4D Pharma reveals progress in phase 2 trial of live biotherapeutic candidate in bladder cancer
The AIM-traded firm was presenting a trial-in-progress poster at the 2022 American Society of Clinical Oncology (ASCO) annual meeting in Chicago.
The AIM-traded firm was presenting a trial-in-progress poster at the 2022 American Society of Clinical Oncology (ASCO) annual meeting in Chicago.
As part of a wider expansion project, Merck commits to expanding an existing facility and building an entirely new one, as part of its strategy to focus on investment in Ireland.
The South Korean company moves to include the raw materials behind mRNA vaccines as part of its CDMO package.